Treating Sleep Disorders in Alzheimer’s Patients



Sleep disturbances in older adults with AD are common and are the result of numerous factors including normal and pathological changes in the aging brain, environment factors, medical or psychiatric morbidity, and medication side effects. Because of the multifaceted nature of sleep disturbances and fragility of older adult patients with dementia, nonpharmacologic interventions are recommended as the first-line treatment modality. Pharmacologic agents can useful, but medication selections should be made cautiously and take into account potential adverse events need to be considered as part of the diagnostic and treatment planning.

Rita Hargrave, MD, is a geriatric psychiatrist at the Martinez VA Outpatient Mental Health Clinic in Martinez, California.


  1. Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med. 2007; 4(Suppl 4):S27–S34112).
  2. Gaugler JE, et al. Predictors of institutionalization of cognitively impaired elders: family help and the timing of placement. J Gerontol B Psychol Sci Soc Sci. 2000; (4):P247-55.
  3. Cotter VT. The burden of dementia. Am J Manag Care. 2007; 13(Suppl 8):S193–S197.
  4. McCleery J, et al. Pharmacotherapies for sleep disturbances in Alzheimer’s Disease. Cochrane Database Syst Rev. 2014 Mar 21; 3:CD009178.
  5. Vitiello MV, et al. Sleep in Alzheimer’s disease and the sundown syndrome. Neurology. 1992; 42(7 Suppl 6):83-93; discussion 93-4.
  6. McCurry SM, et al. Treatment of sleep disturbance in Alzheimer’s disease. Sleep Med Rev. 2000; 4:603–608.
  7. Sultzer DL, et al. Clinical symptom responses to atypical antipsychotic medications in Alzheimer’s disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry. 2008; 165:844–854.
  8. Smith SS, et al. Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea. J Clin Sleep Med. 2006; 2:156–162.
  9. Deschenes CL and McCurry SM. Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep. 2009; 11:20.
  10. Bliwise DL. Dementias. Clin Cornerstone. 2004; 6 Suppl 1A:S16-28.
  11. Carmargos EF, et al. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. Am J Geriatr Psychiatry. 2014; 22(12):1565-74.
  12. Schneider L, et al. Risk of death with atypical antipsychotic drug treatment. JAMA. 2005; 294:1934-1943.
  13. Coupland C, et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011; 343:d4551.
  14. Caterino JM, et al. Inappropriate medication administration to the acutely ill elderly: a nationwide emergency department study, 1992−2000. J Am Geriatr Soc. 2004; 52:1847–1855.
  15. Chesson A, et al. Practice parameters for the use of light therapy in the treatment of sleep disorders. Sleep. 1999; 22:641–660.
  16. Morgenthaler TI, et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep. 2007; 30:1445–1459.
  17. Baehr EK, et al. Circadian phase-shifting effects of nocturnal exercise in older compared with young adults. Am J Physiol Regul Integr Comp Physiol. 2003; 284:R1542–R1550.
  18. King AC, et al. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA. 1997; 277:32–37.
  19. McCurry SM and Ancoli-Israel S. Sleep dysfunction in Alzheimer’s disease and other dementias. Curr Treat Options Neurol. 2003; 5:261–272.